Pathway specific effects of ADSL deficiency on neurodevelopment

  1. Ilaria Dutto
  2. Julian Gerhards
  3. Antonio Herrera
  4. Olga Souckova
  5. Václava Škopová
  6. Jordann Smak
  7. Alexandra Junza
  8. Oscar Yanes
  9. Cedric Boeckx Prof
  10. Martin D Burkhalter
  11. Marie Zikánová
  12. Sebastian Pons
  13. Melanie Philipp
  14. Jens Lüders
  15. Travis H Stracker  Is a corresponding author
  1. Institute for Research in Biomedicine, Spain
  2. University of Tubingen, Germany
  3. Instituto de Biología Molecular de Barcelona, Spain
  4. Charles University, Czech Republic
  5. National Cancer Institute, United States
  6. Spanish Biomedical Research Center in Diabetes and Associated Metabolic Disorders, Spain
  7. University of Barcelona, Spain
  8. University of Tübingen, Germany

Abstract

Adenylosuccinate Lyase (ADSL) functions in de novo purine biosynthesis (DNPS) and the purine nucleotide cycle. ADSL deficiency (ADSLD) causes numerous neurodevelopmental pathologies, including microcephaly and autism spectrum disorder. ADSLD patients have normal serum purine nucleotide levels but exhibit accumulation of dephosphorylated ADSL substrates, S-Ado and SAICAr, the latter being implicated in neurotoxic effects through unknown mechanisms. We examined the phenotypic effects of ADSL depletion in human cells and their relation to phenotypic outcomes. Using specific interventions to compensate for reduced purine levels or modulate SAICAr accumulation, we found that diminished AMP levels resulted in increased DNA damage signaling and cell cycle delays, while primary ciliogenesis was impaired specifically by loss of ADSL or administration of SAICAr. ADSL deficient chicken and zebrafish embryos displayed impaired neurogenesis and microcephaly. Neuroprogenitor attrition in zebrafish embryos was rescued by pharmacological inhibition of DNPS, but not increased nucleotide concentration. Zebrafish also displayed phenotypes commonly linked to ciliopathies. Our results suggest that both reduced purine levels and impaired DNPS contribute to neurodevelopmental pathology in ADSLD and that defective ciliogenesis may influence the ADSLD phenotypic spectrum.

Data availability

Most data generated or analysed during this study are included in the manuscript and supporting source data files. Additional source data is available via Figshare, https://doi.org/10.25452/figshare.plus.c.5793614

The following data sets were generated

Article and author information

Author details

  1. Ilaria Dutto

    Institute for Research in Biomedicine, Barcelona, Spain
    Competing interests
    No competing interests declared.
  2. Julian Gerhards

    Department of Experimental and Clinical Pharmacology and Pharmacogenomics, University of Tubingen, Tubingen, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7005-1618
  3. Antonio Herrera

    Department of Cell Biology, Instituto de Biología Molecular de Barcelona, Barcelona, Spain
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6248-1001
  4. Olga Souckova

    Department of Paediatrics and Inherited Metabolic Disorders, Charles University, Prague, Czech Republic
    Competing interests
    No competing interests declared.
  5. Václava Škopová

    Department of Paediatrics and Inherited Metabolic Disorders, Charles University, Prague, Czech Republic
    Competing interests
    No competing interests declared.
  6. Jordann Smak

    Center for Cancer Research, Radiation Oncology Branch, National Cancer Institute, Bethesda, United States
    Competing interests
    No competing interests declared.
  7. Alexandra Junza

    Spanish Biomedical Research Center in Diabetes and Associated Metabolic Disorders, Madrid, Spain
    Competing interests
    No competing interests declared.
  8. Oscar Yanes

    Spanish Biomedical Research Center in Diabetes and Associated Metabolic Disorders, Madrid, Spain
    Competing interests
    No competing interests declared.
  9. Cedric Boeckx Prof

    Institute of Complex Systems, University of Barcelona, Barcelona, Spain
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8882-9718
  10. Martin D Burkhalter

    Department of Experimental and Clinical Pharmacology and Pharmacogenomics, University of Tübingen, Tübingen, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8646-3131
  11. Marie Zikánová

    Department of Paediatrics and Inherited Metabolic Disorders, Charles University, Prague, Czech Republic
    Competing interests
    No competing interests declared.
  12. Sebastian Pons

    Department of Cell Biology, Instituto de Biología Molecular de Barcelona, Barcelona, Spain
    Competing interests
    No competing interests declared.
  13. Melanie Philipp

    Department of Experimental and Clinical Pharmacology and Pharmacogenomics, University of Tubingen, Tubingen, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2714-965X
  14. Jens Lüders

    Institute for Research in Biomedicine, Barcelona, Spain
    Competing interests
    Jens Lüders, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9018-7977
  15. Travis H Stracker

    Center for Cancer Research, Radiation Oncology Branch, National Cancer Institute, Bethesda, United States
    For correspondence
    travis.stracker@nih.gov
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8650-2081

Funding

H2020 Marie Skłodowska-Curie Actions (754510)

  • Ilaria Dutto

Ministerio de Ciencia, Innovación y Universidades (PGC2018-099562-B-I00)

  • Jens Lüders

Ministerio de Ciencia, Innovación y Universidades (PGC2018-095616-B-I00)

  • Travis H Stracker

Deutsche Forschungsgemeinschaft (DFG PH144/4-1)

  • Melanie Philipp

Deutsche Forschungsgemeinschaft (PH144/6-1)

  • Melanie Philipp

Agència de Gestió d'Ajuts Universitaris i de Recerca (2017 SGR)

  • Jens Lüders
  • Travis H Stracker

Charles University (PROGRES Q26/LF1)

  • Olga Souckova
  • Václava Škopová
  • Marie Zikánová

Ministry of Science, Innovation and Universities (BFU2017-83562-P)

  • Sebastian Pons

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 1,815
    views
  • 260
    downloads
  • 13
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ilaria Dutto
  2. Julian Gerhards
  3. Antonio Herrera
  4. Olga Souckova
  5. Václava Škopová
  6. Jordann Smak
  7. Alexandra Junza
  8. Oscar Yanes
  9. Cedric Boeckx Prof
  10. Martin D Burkhalter
  11. Marie Zikánová
  12. Sebastian Pons
  13. Melanie Philipp
  14. Jens Lüders
  15. Travis H Stracker
(2022)
Pathway specific effects of ADSL deficiency on neurodevelopment
eLife 11:e70518.
https://doi.org/10.7554/eLife.70518

Share this article

https://doi.org/10.7554/eLife.70518

Further reading

    1. Cell Biology
    Affiong Ika Oqua, Kin Chao ... Alejandra Tomas
    Research Article

    G protein-coupled receptors (GPCRs) are integral membrane proteins which closely interact with their plasma membrane lipid microenvironment. Cholesterol is a lipid enriched at the plasma membrane with pivotal roles in the control of membrane fluidity and maintenance of membrane microarchitecture, directly impacting on GPCR stability, dynamics, and function. Cholesterol extraction from pancreatic beta cells has previously been shown to disrupt the internalisation, clustering, and cAMP responses of the glucagon-like peptide-1 receptor (GLP-1R), a class B1 GPCR with key roles in the control of blood glucose levels via the potentiation of insulin secretion in beta cells and weight reduction via the modulation of brain appetite control centres. Here, we unveil the detrimental effect of a high cholesterol diet on GLP-1R-dependent glucoregulation in vivo, and the improvement in GLP-1R function that a reduction in cholesterol synthesis using simvastatin exerts in pancreatic islets. We next identify and map sites of cholesterol high occupancy and residence time on active vs inactive GLP-1Rs using coarse-grained molecular dynamics (cgMD) simulations, followed by a screen of key residues selected from these sites and detailed analyses of the effects of mutating one of these, Val229, to alanine on GLP-1R-cholesterol interactions, plasma membrane behaviours, clustering, trafficking and signalling in INS-1 832/3 rat pancreatic beta cells and primary mouse islets, unveiling an improved insulin secretion profile for the V229A mutant receptor. This study (1) highlights the role of cholesterol in regulating GLP-1R responses in vivo; (2) provides a detailed map of GLP-1R - cholesterol binding sites in model membranes; (3) validates their functional relevance in beta cells; and (4) highlights their potential as locations for the rational design of novel allosteric modulators with the capacity to fine-tune GLP-1R responses.

    1. Cell Biology
    2. Genetics and Genomics
    Keva Li, Nicholas Tolman ... UK Biobank Eye and Vision Consortium
    Research Article

    A glaucoma polygenic risk score (PRS) can effectively identify disease risk, but some individuals with high PRS do not develop glaucoma. Factors contributing to this resilience remain unclear. Using 4,658 glaucoma cases and 113,040 controls in a cross-sectional study of the UK Biobank, we investigated whether plasma metabolites enhanced glaucoma prediction and if a metabolomic signature of resilience in high-genetic-risk individuals existed. Logistic regression models incorporating 168 NMR-based metabolites into PRS-based glaucoma assessments were developed, with multiple comparison corrections applied. While metabolites weakly predicted glaucoma (Area Under the Curve = 0.579), they offered marginal prediction improvement in PRS-only-based models (p=0.004). We identified a metabolomic signature associated with resilience in the top glaucoma PRS decile, with elevated glycolysis-related metabolites—lactate (p=8.8E-12), pyruvate (p=1.9E-10), and citrate (p=0.02)—linked to reduced glaucoma prevalence. These metabolites combined significantly modified the PRS-glaucoma relationship (Pinteraction = 0.011). Higher total resilience metabolite levels within the highest PRS quartile corresponded to lower glaucoma prevalence (Odds Ratiohighest vs. lowest total resilience metabolite quartile=0.71, 95% Confidence Interval = 0.64–0.80). As pyruvate is a foundational metabolite linking glycolysis to tricarboxylic acid cycle metabolism and ATP generation, we pursued experimental validation for this putative resilience biomarker in a human-relevant Mus musculus glaucoma model. Dietary pyruvate mitigated elevated intraocular pressure (p=0.002) and optic nerve damage (p<0.0003) in Lmx1bV265D mice. These findings highlight the protective role of pyruvate-related metabolism against glaucoma and suggest potential avenues for therapeutic intervention.